Neurosciences articles for UCL, United Kingdom (UK)

Time frame: 1 June 2025 - 30 May 2026

View topic

Count: 71

Article ‘Count’ for Neurosciences.

Journal Count Share
1 0.05
BLOC1S1 variants cause lysosomal and autophagic defects resulting in a hypomyelinating leukodystrophy with epileptic encephalopathy 0.05
10 2.21
Diagnostic, Prognostic Value, and Pathological Associations of Levodopa Responsiveness in Parkinson's Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy 0.81
Alzheimer's Disease Co‐Pathology and Cognitive Impairment in Amyotrophic Lateral Sclerosis 0.01
Individualized Atrophy‐Based Prediction of Dementia Progression in Familial Frontotemporal Lobar Degeneration With Bayesian Linear Mixed‐Effects Modeling 0.10
Mutations in the Key Autophagy Tethering Factor scpEPG5/scp Link Neurodevelopmental and Neurodegenerative Disorders Including Early‐Onset Parkinsonism 0.06
Skeletal Muscle Biomarkers of Amyotrophic Lateral Sclerosis: A Large‐Scale, Multi‐Cohort Proteomic Study 0.06
Clinical–Radiological Spectrum of Cerebral Amyloid Angiopathy‐Related Inflammation 0.40
Clinical and Molecular Genetic Characterization of Landau Kleffner Syndrome: An Observational Cohort and Experimental Study 0.47
iHCN2/i‐Associated Neurodevelopmental Disorders: Data from Patients and iXenopus/i Cell Models 0.04
Heart Rate Profiles During Exercise and Incident Parkinson's Disease 0.10
Deep Brain Stimulation for scpiVPS16/i/scp‐Related Dystonia: A Multicenter Study 0.18
11 3.26
Nav1.5 in the dorsal root ganglion plays a crucial role in mechanical hypersensitivity 0.27
A cause and protective treatment for acute and progressive disability and grey matter atrophy 0.67
Immune alterations in schizophrenia and the effects of a therapeutic antibody: a neuroimaging study 0.13
Enhanced adenoviral reactivity in Guillain-Barré syndrome after SARS-CoV-2 infection and vaccination 0.24
Cortical tau deposition promotes atrophy in connected white matter regions in Alzheimer’s disease 0.01
Quantitative susceptibility mapping reveals differences between subtypes of Lewy body dementia 0.63
Associations between epilepsy-related polygenic risk and brain morphology in childhood 0.02
The influence of the glymphatic system on α-synuclein propagation: the role of aquaporin-4 1.00
Amygdalar and hippocampal volume loss in limbic-predominant age-related TDP-43 encephalopathy 0.03
A digital motor score for sensitive detection of progression in Huntington’s disease 0.18
Charcot-Marie-Tooth disease type 1E: clinical natural history and molecular impact of iPMP22/i variants 0.08
1 0.04
Detecting alpha-synuclein aggregates with small molecules on single-molecule array 0.04
1 0.01
Frequency and Clinical Outcomes Associated With Tau Positron Emission Tomography Positivity 0.01
1 0.50
Lysosomal TPC2 channels disrupt Ca2+ entry and dopaminergic function in models of LRRK2-Parkinson’s disease 0.50
2 0.43
Pathogenic variants in BORCS5 Cause a Spectrum of Neurodevelopmental and Neurodegenerative Disorders with Lysosomal Dysfunction 0.13
Biallelic variants in ARHGAP19 cause a progressive inherited motor-predominant neuropathy 0.30
1 0.45
Non‐invasive assessment of integrated cardiorespiratory network dynamics after physiological stress in humans 0.45
1 0.11
Cortical microstructure is associated with disease severity and clinical progression in genetic frontotemporal dementia: a GENFI study 0.11
2 0.99
Intestinal macrophages modulate synucleinopathy along the gut–brain axis 0.33
A probabilistic histological atlas of the human brain for MRI segmentation 0.65
13 2.59
Dysfunction of the episodic memory network in the Alzheimer’s disease cascade 0.01
Variants in the proteasome regulator PSMF1 cause a phenotypic spectrum from parkinsonism to perinatal lethality 0.19
An in vivo and in vitro spatiotemporal profile of human midbrain development 0.77
Evidence for divergent cortical organisation in Parkinson’s disease and Lewy Body Dementia 0.67
A wireless optogenetic stimulation system for long-term function evaluation of mice forelimb with sub-nerve resolution 0.08
Isotope-encoded spatial biology identifies plaque-age-dependent maturation and synaptic loss in an Alzheimer’s disease mouse model 0.33
CSF total tau as a proxy of synaptic degeneration 0.01
Two-step detection of Lewy body pathology via smell-function testing and CSF α-synuclein seed amplification 0.03
A human brain network linked to restoration of consciousness after deep brain stimulation 0.02
Synaptic loss pattern is constrained by brain connectome and modulated by phosphorylated tau in Alzheimer’s disease 0.02
Cell-specific mechanisms drive connectivity across the time course of Huntington’s disease 0.42
Glial reactivity correlates with synaptic dysfunction across aging and Alzheimer’s disease 0.01
Intracellular accumulation of amyloid-ß is a marker of selective neuronal vulnerability in Alzheimer’s disease 0.06
1 0.04
Population attributable fractions of a wide range of peripheral diseases for the burden of dementia 0.04
3 0.25
Microbiome signature of Parkinson’s disease in healthy and genetically at-risk individuals 0.16
LRRK2-targeting antisense oligonucleotide in Parkinson’s disease: a phase 1 randomized controlled trial 0.03
Oral splicing modulator branaplam in Huntington’s disease: a phase 2 randomized controlled trial 0.06
4 0.26
The Alzheimer’s therapeutic Lecanemab attenuates Aβ pathology by inducing an amyloid-clearing program in microglia 0.01
Microglia modulate Aβ-dependent astrocyte reactivity in Alzheimer’s disease 0.01
TDP-43-dependent mis-splicing of KCNQ2 triggers intrinsic neuronal hyperexcitability in ALS/FTD 0.22
Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, genotype and sex 0.03
1 0.35
Alzheimer’s disease pathology degrades an NMDA receptor-dependent spontaneous activity pattern in cortico-hippocampal circuits 0.35
2 0.38
Association between gabapentinoid treatment, concurrent use with opioid or benzodiazepine and the risk of drug poisoning: A self-controlled case series study 0.35
Associations between falls and other serious adverse events and antihypertensive medication in individuals with dementia: An observational cohort study 0.03
1 0.38
Analgesia through FKBP51 inhibition at disease onset confers lasting relief from sensory and emotional chronic pain symptoms 0.38
2 0.54
GPNMB is a biomarker for lysosomal dysfunction and is secreted via LRRK2-modulated lysosomal exocytosis 0.52
The chloride intracellular channel 1 (CLIC1) is essential for microglial morphodynamics and neuroinflammation 0.01
3 1.15
Lowering the HTT1a transcript as an effective therapy for Huntington’s disease in a knockin mouse model 0.62
Selective targeting of mutant huntingtin intron 1 improves rescue provided by antisense oligonucleotides in Huntington’s disease mice 0.50
Levetiracetam prevents Aβ production through SV2a-dependent modulation of APP processing in Alzheimer’s disease models 0.03
2 0.26
Direct interaction between TDP-43 and Tau promotes their co-condensation, while suppressing Tau fibril formation and seeding 0.05
Tau uptake by human neurons depends on receptor LRP1 and kinase LRRK2 0.21
4 0.34
Efficacy and safety of the CD40 ligand inhibitor dapirolizumab pegol in systemic lupus erythematosus (PHOENYCS GO): a randomised, double-blind, placebo-controlled, phase 3 trial 0.06
Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials 0.02
Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial 0.21
Risk markers for sudden unexpected death in epilepsy: an observational, prospective, multicentre cohort study 0.06
3 0.58
Association between the Edinburgh CT and genetic diagnostic criteria for cerebral amyloid angiopathy-associated lobar intracerebral haemorrhage and recurrent intracerebral haemorrhage: an individual patient data meta-analysis 0.05
Sleep EEG and respiratory biomarkers of sudden unexpected death in epilepsy (SUDEP): a case–control study 0.05
Diagnostic and prognostic value of α-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort study 0.49
1 0.03
Zorevunersen in Children and Adolescents with Dravet Syndrome 0.03

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.